References:

[1] Borzelleca, JF and Cherrick, HM, The excretion of drugs in saliva. Antibiotics., Journal of Oral Therapeutics and Pharmacology 2 (1965) 180.
[2] Horning, Marjorie G and Brown, Linda and Nowlin, Jean and Lertratanangkoon, Khing and Kellaway, Peter and Zion, Tomas E, Use of saliva in therapeutic drug monitoring, Clinical Chemistry
23 (1977) 157–164.
[3] Drummer, Olaf H, Drug testing in oral fluid, Clinical Biochemist Reviews 27 (2006) 147.
[4] Quintela, Oscar and Crouch, Dennis J and Andrenyak, David M, Recovery of drugs of abuse from the Immunalysis Quantisal oral fluid collection device, Journal of Analytical Toxicology 30 (2006)
614–616.
[5] Tang, Magdalene HY and Ching, CK and Poon, Simon and Chan, Suzanne SS and Ng, WY and Lam, M and Wong, CK and Pao, Ronnie and Lau, Angus and Mak, Tony WL, Evaluation of three rapid oral fluid test devices on the screening of multiple drugs of abuse including ketamine, Forensic Science International 286 (2018) 113–120.
[6] Gröschl, Michael, Saliva: a reliable sample matrix in bioanalytics, Bioanalysis 9 (2017) 655–668.
[7] Vindenes, V and Yttredal, B and Øiestad, EL and Waal, H and Bernard, JP and Mørland, JG and Christophersen, AS, Oral fluid is a viable alternative for monitoring drug abuse: detection of drugs
in oral fluid by liquid chromatography-tandem mass spectrometry and comparison to the results from urine samples from patients treated with methadone or buprenorphine, Journal of Analytical
Toxicology 35 (2011) 32–39.
[8] Doyon, Alexandra and Paradis-Tanguay, Laurence and Crispino, Frank and Lajeunesse, André, Les analyses médico-légales de salives: expertise vis-à-vis l’analyse des drogues, Canadian Society of Forensic Science Journal 50 (2017) 90–102.
[9] Wille, Sarah MR and Di Fazio, Vincent and Toennes, Stefan W and van Wel, Janelle HP and Ramaekers, Johannes G and Samyn, Nele, Evaluation of Δ9-tetrahydrocannabinol detection using DrugWipe5S screening and oral fluid quantification after Quantisal collection for roadside drug detection via a controlled study with chronic cannabis users, Drug Testing and Analysis 7 (2015)
178–186.
[10] Cohier, Camille and Mégarbane, Bruno and Roussel, Olivier, Illicit drugs in oral fluid: Evaluation of two collection devices, Journal of Analytical Toxicology 41 (2017) 71–76.
[11] Krotulski, Alex J and Mohr, Amanda LA and Friscia, Melissa and Logan, Barry K, Field detection of drugs of abuse in oral fluid using the Alere DDS 2 mobile test system with confirmation by
liquid chromatography tandem mass spectrometry (LC–MS/MS), Journal of Analytical Toxicology 42 (2017) 170–176.
[12] Viel E. The year Canada became green - an overview of the legislation surrounding cannabis legalization in Canada. TIAFT
Bulletin 2018; 48(4): 21–25.
[13] S. M. Wille, V. Di Fazio, N. Samyn, La salive dans les investigations toxicologiques: considérations pratiques et analytiques, in: P. Kintz (Ed.), Traité De Toxicologie Médico-judiciaire, Elsevier Masson, Paris, 2012, pp. 219–255.
[14] Verstraete, Alain G, Oral fluid testing for driving under the influence of drugs: history, recent progress and remaining challenges, Forensic Science International 150 (2005) 143–150.
[15] Justice Canada, S.C. 2018, c. 16: Cannabis Act, Standard, https://lawslois.justice.gc.ca/eng/acts/C-24.5/, Ottawa, Canada, 2018.
[16] Parliament of Canada, S.C. 2018, c. 21: Bill C-46 – An Act to amend the Criminal Code (offences relating to conveyances) and to make consequential amendments to other Acts, Standard,
http://www.parl.ca/DocumentViewer/en/42-1/bill/C-46/royal-assent, Ottawa, Canada, 2018.
[17] Justice Canada, SOR/2018-179: Approved Drug Screening Equipment Order, Standard, https://laws-lois.justice.gc.ca/PDF/SOR-2018-179.pdf, Ottawa, Canada, 2018.
[18] Canadian Society of Forensic Science Drugs and Driving Committee, Drug Screening Equipment – Oral Fluid Standards and Evaluation Procedures, Standard, https://www.csfs.ca/wpcontent/
uploads/2017/11/Approval-Standards-for-Drug-Screening-Equipment.pdf, Ottawa, Canada, 2017.
[19] Justice Canada, Order Amending the Approved Drug Screening Equipment Order, Standard, http://www.gazette.gc.ca/rp-pr/p1/2019/2019-04-20/html/reg4-eng.html, Ottawa, Canada, 2019.
[20] Edwards, Lorrine D and Smith, Katherine L and Savage, Theodore, Drugged driving in Wisconsin: oral fluid versus blood, Journal of Analytical Toxicology 41 (2017) 523–529.
[21] Strano-Rossi, Sabina and Castrignano, Erika and Anzillotti, Luca and Serpelloni, Giovanni and Mollica, Roberto and Tagliaro, Franco and Pascali, Jennifer P and Di Stefano, Delfina and Sgalla,
Roberto and Chiarotti, Marcello, Evaluation of four oral fluid devices (DDS, Drugtest 5000, Drugwipe 5+ and RapidSTAT) for on-site monitoring drugged driving in comparison with UHPLC–MS/MS analysis, Forensic Science International 221 (2012) 70–76.
[22] Veitenheimer, Allison M and Wagner, Jarrad R, Evaluation of Oral Fluid as a Specimen for DUID, Journal of Analytical Toxicology 41 (2017) 517–522.
[23] Furuhaugen, Havard and Jamt, Ragnhild EG and Nilsson, Galina and Vindenes, Vigdis and Gjerde, Hallvard, Roadside survey of alcohol and drug use among Norwegian drivers in 2016–2017: A followup of the 2008–2009 survey, Traffic Injury Prevention 19 (2018) 555–562.
[24] Viel, Édith and Blais, Estelle and Mireault, Pascal, Statistical overview of drug findings in urine sample from the DRE program in the province of Qu´ebec, Canada, Standard, 2013 Society of
Forensic Toxicologists Meeting (SOFT), Orlando, USA, 2013.
[25] Standard Practices for Method Validation in Forensic Toxicology (Draft). standard, American Academy of Forensic
Sciences Standards Board; Colorado Springs, United States: 2018.
[26] Camirand Lemyre F, Desharnais B, Laquerre J, et al. Qualitative threshold method validation and uncertainty evaluation:
A theoretical framework and application to a 40 analytes liquid chromatography–tandem mass spectrometry method. Drug
Testing and Analysis 2020; 12(9): 1287–1297. doi: 10.1002/dta.2867
[27] ISO/IEC 17025:2005, General requirements for the competence of testing and calibration laboratories, Standard, International Organization for Standardization, Geneva, Switzerland, 2005.
[28] ISO/IEC 17025:2017, General requirements for the competence of testing and calibration laboratories, Standard, International Organization for Standardization, Geneva, Switzerland, 2017.
[29] D. Menasco, C. Summit, J. Neifeld, S. Marin, L. Williams, E. Gairloch, Practical Considerations using Quantisal Oral Fluid Collection Devices & SPE Method Development by Polymeric Mixed- Mode Cation Exchange, Standard, Annual Congress in Clinical Mass Spectrometry, Palm Springs, USA, 2018.
[30] R. Gudihal, S. Babu CV, N. Tang, S. Palaniswamy, U. S, S. Basingi, Analysis of Polyethylene Glycol (PEG) and a Mono and Di-PEGylated Therapeutic Protein Using HPLC and Q-TOF Mass
Spectrometry, Standard, Agilent Technologies, 2012.
[31] CAN-P-1578, Guidelines for the Accreditation of Forensic Testing Laboratories, Standard, Standards Council of Canada (Conseil canadien des normes), Ottawa, Canada, 2009.
[32] Logan BK, D’Orazio AL, Mohr AL, et al. Recommendations for toxicological investigation of drug-impaired driving and
motor vehicle fatalities – 2017 update. Journal of Analytical Toxicology 2018; 42(2): 63–68. doi: 10.1093/jat/bkx082
[33] European Medicines Agency . Guideline on bioanalytical method validation. standard,
https://www.ema.europa.eu/documents/scientific-guideline/guideline-bioanalytical-method-validation_en.pdf; London,
United Kingdom: 2011.
[34] European Commission Directorate General for Health and Food Safety . Guidance document on analytical quality
control and method validation procedures for pesticide residues and analysis in food and feed. standard,
https://ec.europa.eu/food/sites/food/files/plant/docs/pesticides_mrl_guidelines_wrkdoc_2017-11813.pdf; : 2017.
[35] Côté, Cynthia and Desharnais, Brigitte and Morel, Marc-André and Laquerre, Julie and Taillon, Marie-Pierre and Daigneault, Gabrielle and Skinner, Cameron D and Mireault, Pascal, High
Throughput Protein Precipitation: Screening and Quantification of 106 Drugs and their Metabolites using LC-MS/MS, Standard, 2017 Society of Forensic Toxicologists Meeting (SOFT) and 55th
Annual Meeting of the International Association of Forensic Toxicologists (TIAFT), Boca Raton, USA, 2018.
[36] Fabresse, Nicolas and Aouad, Hassan and Knapp, Adeline and Mayer, Charlotte and Etting, Isabelle and Larabi, Islam Amine and Alvarez, Jean-Claude, Development and validation of a liquid
chromatography-tandem mass spectrometry method for simultaneous detection of 10 illicit drugs in oral fluid collected with FLOQSwabs and application to real samples, Drug Testing and Analysis 11 (2019) 824–832.
[37] Leverence, Rachael and Avery, Michael J and Kavetskaia, Olga and Bi, Honggang and Hop, Cornelis ECA and Gusev, Arkady I, Signal suppression/enhancement in HPLC-ESI-MS/MS from
concomitant medications, Biomedical Chromatography 21 (2007) 1143–1150.
[38] Lee, Dayong and Milman, Garry and Barnes, Allan J and Goodwin, Robert S and Hirvonen, Jussi and Huestis, Marilyn A, Oral fluid cannabinoids in chronic, daily cannabis smokers during sustained, monitored abstinence, Clinical Chemistry 57 (2011) 1127–1136.
[39] Drummer OH, Gerostamoulos D, Chu M, Swann P, Boorman M, Cairns I. Drugs in oral fluid in randomly selected drivers.
Forensic Science International 2007; 170(2-3): 105–110. doi: 10.1016/j.forsciint.2007.03.028
[40] Saar, Eva and Gerostamoulos, Dimitri and Drummer, Olaf H and Beyer, Jochen, Assessment of the stability of 30 antipsychotic drugs in stored blood specimens, Forensic Science International
215 (2012) 152–158.
[41] Mata, Dani C, Stability of 26 sedative hypnotics in six toxicological matrices at different storage conditions, Journal of Analytical Toxicology 40 (2016) 663–668.
[42] Crouch DJ. Oral fluid collection: the neglected variable in oral fluid testing. Forensic Science International 2005; 150(2-3):
165–173. doi: 10.1016/j.forsciint.2005.02.028
[43] Ventura M, Pichini S, Ventura R, et al. Stability of drugs of abuse in oral fluid collection devices with purpose of external
quality assessment schemes. Therapeutic Drug Monitoring 2009; 31(2): 277–280. doi: 10.1097/FTD.0b013e318198670b
[44] Ventura M, Pichini S, Ventura R, Zuccaro P, Pacifici R, Torre d. lR. Stability studies of principal illicit drugs in oral fluid:
preparation of reference materials for external quality assessment schemes. Therapeutic Drug Monitoring 2007; 29(5):
662–665. doi: 10.1097/FTD.0b013e318156e892